首页> 外国专利> Cysteine-depleted interferon-beta muteins, their preparation, compositions containing them, and structural genes, vectors and organisms, and their propagation, suitable for use in the preparation of the muteins.

Cysteine-depleted interferon-beta muteins, their preparation, compositions containing them, and structural genes, vectors and organisms, and their propagation, suitable for use in the preparation of the muteins.

机译:消除半胱氨酸的干扰素-β突变蛋白,其制备,包含它们的组合物以及结构基因,载体和生物及其繁殖,适用于制备突变蛋白。

摘要

The invention provides muteins of biologically active proteins such as IFN- beta and IL-2 in which cysteine residues that are not essential to biological activity have been deleted or replaced with other amino acids to eliminate sites for intermolecular crosslinking or incorrect intramolecular disulfide bridge formation. These muteins may be made via bacterial expression of mutant genes that encode the muteins and have been synthesized from the genes for the parent proteins by oligonucleotide-directed mutagenesis.
机译:本发明提供了生物学活性蛋白例如IFN-β和IL-2的突变蛋白,其中对生物学活性不是必需的半胱氨酸残基已经被缺失或被其他氨基酸取代,以消除分子间交联或不正确的分子内二硫键形成的位点。这些突变蛋白可以通过编码突变蛋白的突变基因的细菌表达来制备,并且已经通过寡核苷酸定向诱变从亲本蛋白的基因合成了突变蛋白。

著录项

  • 公开/公告号NL960013I1

    专利类型

  • 公开/公告日1996-10-01

    原文格式PDF

  • 申请/专利权人 SCHERING AKTIENGESELLSCHAFT;

    申请/专利号NL19960960013C

  • 发明设计人

    申请日1996-05-29

  • 分类号C07K14/555;A61K31;A61K35/74;A61K38;A61K38/21;A61P31/12;A61P35;A61P37;C07H;C07H21/04;C07K;C07K9;C07K14;C07K14/005;C07K14/195;C07K14/52;C07K14/525;C07K14/53;C07K14/54;C07K14/55;C07K14/56;C07K14/565;C07K19;C12N1/20;C12N1/21;C12N15;C12N15/09;C12N15/10;C12P;C12P19/34;C12P21;C12P21/02;C12R1/19;

  • 国家 NL

  • 入库时间 2022-08-22 03:53:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号